Sep 09, 2019 / 12:10PM GMT
Unidentified Analyst -
(technical difficulty)
Therapeutics.
Before we get into the Q&A, I have to read a disclosure. So before we get started, I just need to let you know that for all important disclosures, please see the Morgan Stanley research disclosures website at www.morganstanley.com/researchdisclosures.
Okay. Sandy, thank you for being with us.
Alexander D. Macrae - Sangamo Therapeutics, Inc. - CEO, President & Director
My pleasure.
Unidentified Analyst -
So before we get into kind of program-specific Q&A, maybe it's good if you could just provide a couple of minutes of opening remarks about some of your key corporate highlights and then we can go from there.
Alexander D. Macrae - Sangamo Therapeutics, Inc. - CEO, President & Director
Thank you. So Sangamo is a fascinating company. It's a genomic medicine company, and we can do gene therapy, cell
Sangamo Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers